|
123 Pharmacy
welcomes health and social care paper Pharmacy organisations
have broadly welcomed this week's Government White Paper on health and
social care, which calls for an expansion of the role of pharmacists
in primary care ...more
123 Pharmacists
report a fifth of adverse drug reactions sent to MHRA Nearly one in five adverse drug reaction reports sent to the Medicines and Healthcare products Regulatory Agency comes from a pharmacist
...more
123 Prescriptions
rise by 4.5 per cent in England and Wales Community pharmacies in England and Wales dispensed almost 675 million prescriptions in 2004–05 — a 4.5 per cent increase on the previous year, according to Government statistics released this week
...more
124 Half of Lipitor
recalled in counterfeit scare was fake Over 50 per cent of
Lipitor (atorvastatin) packs recalled from pharmacies by Pfizer in a
counterfeit scare last year were fake ...more
124 New angina
drug has unique mode of action Ivabradine, a new drug that
can be prescribed for patients with chronic stable angina who are intolerant
of beta-blockers, was launched by Servier this week ...more
124 European
Medicines Agency reviews cases of liver injury associated with telithromycin A preliminary review of cases of serious liver injury associated with telithromycin (Ketek) has led the European Medicines Agency to ask for warnings concerning liver disorders to be strengthened in product information
...more
124 Keele accepts
students this year Keele University has been granted approval
by the Royal Pharmaceutical Society to accept students onto its new MPharm
course in September 2006 ...more
124 Animal rights
extremists less active compared with 2004 Damage to company,
personal and public property by animal rights extremists nearly halved
last year compared with 2004, according to recent figures from the Association
of the British Pharmaceutical Industry ...more
125 Prescription
charge overhaul for Scotland likely Exemption categories for
NHS prescription charges in Scotland are to be overhauled after consultation,
although charges will remain in place ...more
125 Society presents
evidence at inquiry into NHS charges in England Abolition
of NHS prescription charges in Wales next year could influence what happens
to the system in England, the Royal Pharmaceutical Society predicted
this week ...more
125 Wide regional variations in access to cancer drugs “unacceptable”, says PAC report Regional variations in the supply and prescription of approved cancer drugs have been dubbed “unacceptable” by the All-Party Public Accounts Committee
...more
|
126 LIFT programme
continues to expand this year One new surgery or health centre
is due to open under the Local Improvement Finance Trust (LIFT) programme
every week this year ...more
126 “Know
about pneumo” campaign launched A campaign to raise
awareness of pneumococcal disease has been launched by the British Lung
Foundation, Help the Aged and the Meningitis Research Foundation this
month ...more
126 Uptake of
supplementary prescribing grants slow in Scotland More supplementary
prescribers in Scotland should make use of the grants and payments available
to them, the Scottish Pharmaceutical General Council has said ...more
126 NHS reform
manual launched A manual to help guide the NHS in England
through its present reform process was launched by the Department of
Health last week ...more
126 PBC guidance
published Further guidance on practice-based commissioning
has been published by the Department of Health ...more
127 Novo Nordisk
to withdraw animal insulin products Novo Nordisk has announced
that it is withdrawing its animal insulin products from the UK market
in response to dwindling demand ...more
127 Antiplatelet
bleeds assessed Aspirin does not increase the risk of recurring
intracerebral haemorrhage (ICH) in some patients, according to a study
...more
127 Blood glucose
control worse in South Asians Blood glucose levels in South
Asian patients with diabetes are more poorly controlled than in white
patients, a study of 1,767 patients has found ...more
127 COX-2 inhibitor
drugs may reduce the risk of breast cancer Women taking selective
cyclo-oxygenase 2 (COX-2) inhibitor drugs on a daily basis for two or
more years are at reduced risk of breast cancer, according to a case
control study ...more
|
The
Pharmaceutical Journal